Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

      Sun Pharma recalls 2.7 lakh bottles of antidepressant in US

      supriya kashyap kashyap6 Feb 2017 5:12 AM
      New Delhi : Sun Pharma is recalling over 2.7 lakh bottles of bupropion hydrochloride extended-release tablets used for treatment of major depressive...
      UK agency says Pfizer breast cancer drug too expensive

      UK agency says Pfizer breast cancer drug too expensive

      supriya kashyap kashyap6 Feb 2017 5:11 AM
      Pfizer's breast cancer drug Ibrance, or palbociclib, is too expensive to justify its use on Britain's state-run health service, the country's...
      Glenmark Pharma climbs nearly 7 percent on smart Q3 earnings

      Glenmark Pharma climbs nearly 7 percent on smart Q3 earnings

      supriya kashyap kashyap6 Feb 2017 5:10 AM
      New Delhi : Shares of Glenmark Pharmaceuticals jumped nearly 7 per cent after the company reported an over two-fold jump in consolidated net profit...
      Portuguese regulator completes Granules plant re-inspection

      Portuguese regulator completes Granules plant re-inspection

      supriya kashyap kashyap5 Feb 2017 6:45 AM
      New Delhi : Drug firm Granules India said re-inspection of its manufacturing facility at Gagillapur in Telangana has been successfully completed by...
      Merck 2017 forecast reassuring; full-speed ahead with Keytruda

      Merck 2017 forecast reassuring; full-speed ahead with Keytruda

      supriya kashyap kashyap5 Feb 2017 6:45 AM
      Merck & Co Inc (MRK.N), faced with patent expiration's and increasing development costs for its high-profile Keytruda cancer immunotherapy,...
      Amgen cholesterol drug succeeds in cutting serious heart problems: Study

      Amgen cholesterol drug succeeds in cutting serious heart problems: Study

      supriya kashyap kashyap5 Feb 2017 6:35 AM
      Amgen Inc said its potent cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart...
      Will not sell sick pharma firms to foreign companies: Government

      Will not sell sick pharma firms to foreign companies: Government

      supriya kashyap kashyap5 Feb 2017 6:31 AM
      New Delhi : Amid Opposition protests, government said it will not sell sick pharma PSUs BCPL and HAL to foreign firms and closure of IDPL and RDPL...
      Medical, Sales Representatives of Bihar, Jharkhand on strike

      Medical, Sales Representatives of Bihar, Jharkhand on strike

      supriya kashyap kashyap4 Feb 2017 6:49 AM
      Thousand of Medical and Sales Representatives of Bihar and Jharkhand went on a strike in support of some labour and medicine related demands.The...
      Lupin gets final USFDA nod for Mylans skin disease cream

      Lupin gets final USFDA nod for Mylan's skin disease cream

      supriya kashyap kashyap4 Feb 2017 6:40 AM
      New Delhi : Pharma major Lupin said it has received final approval from the US health regulator to market its generic version of Mylan's triamcinolone...
      AstraZeneca Pharma Q3 net up 84 pc to Rs 16 crore

      AstraZeneca Pharma Q3 net up 84 pc to Rs 16 crore

      supriya kashyap kashyap4 Feb 2017 6:40 AM
      Delhi : Drug firm AstraZeneca Pharma reported an 84.08 per cent increase in its standalone net profit at Rs 15.96 crore for the third quarter ended...
      USFDA approves Bristol-Myers Opdivo for bladder cancer

      USFDA approves Bristol-Myers Opdivo for bladder cancer

      supriya kashyap kashyap4 Feb 2017 6:36 AM
      The U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co's Opdivo to include treatment of urothelial carcinoma, the most...
      Dishman Pharma receives EIR report from USFDA

      Dishman Pharma receives EIR report from USFDA

      supriya kashyap kashyap3 Feb 2017 6:57 AM
      New Delhi : Drug firm Dishman Pharmaceuticals and Chemicals Ltd has received Establishment Inspection Report (EIR) from the US health regulator on...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok